Critically ill patients admitted for acute brain injury are exposed to many heath-care associated infections such as ventilator associated pneumoniae (VAP). The PROHYVAP study, published in 2024 reported that a single dose of CEFTRIAXONE as an antibiotic prophylaxis could reduce the incidence of early VAP (VAP that occured between day 2 and day 7 of mechanical ventilation). However, patients with acute brain injury also presented frequently augmented renal clearance (ARC), which could affect the pharmacokinetic and pharmacodynamic target attainment (PK/PD) of antibiotic prophylaxis. This study aims to analyse the PK/PD target attainment after one dose of CEFTRIAXONE in critically ill patients with acute brain injury and to describe the effect of ARC on PK/PD target attainment during early VAP.
Study Type
OBSERVATIONAL
Enrollment
60
CHRU de Nancy - Hôpital Central
Nancy, Lorraine, France
CHRU Nancy - Hopital Central
Nancy, Meurthe-et-Moselle, France
Percentage of patients with PK/PD target attainment
Proportion of patients with serum concentrations of CEFTRIAXONE above the minimal inhibitory concentration (MIC) of 4 mg/mL (in case of undocumented VAP), or \> 4 times the MIC of documented bacteria.
Time frame: 24 hours
Impact of the PK/PD target attainment on the incidence of early ventilator associated pneumoniae
Time frame: Day 7
Association between augmented renal clearance and PK/PD target attainment
Time frame: 24 hours
Association between hyperbilirubinemia and PK/PD target attainment
Time frame: 24 hours
Association between PK/PD target attainment and day 28 mortality
Time frame: Day 28
Association between PK/PD target attainment and ICU length of stay
Time frame: 3 months
Incidence of multi drug resistance bacteria
Time frame: Day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.